An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
C-265 (45)
LEGISinfo Bills
summary for this bill. Stage history and metadata are shown below. House of Commons — First reading: Completed (2026-03-11) House of Commons — Second reading: Completed (2026-06-10) House of Commons — Consideration in committee: No activity LEGISinfo: https://www.parl.ca/legisinfo/en/bill/45-1/c-265